How big is the RPM market?
This blog post has been written by the person who has mapped the remote patient monitoring market in a clean and beautiful presentation
The remote patient monitoring market has emerged as one of healthcare's fastest-growing sectors, driven by an aging population, rising chronic diseases, and post-pandemic digital health adoption.
Valued at $31.2 billion in 2025 with a robust 12.7% annual growth rate, this market presents significant opportunities for entrepreneurs building next-generation monitoring solutions and investors seeking exposure to healthcare's digital transformation. And if you need to understand this market in 30 minutes with the latest information, you can download our quick market pitch.
Summary
The global RPM market reached $31.2 billion in 2025, growing 12.7% from the previous year, with software emerging as the fastest-growing subsegment at 14.8% annual growth. North America dominates with 43.4% market share, while cardiovascular monitoring represents the largest use case at $8.5 billion in revenue.
| Metric | 2025 Value | Growth Rate | 2030 Projection |
|---|---|---|---|
| Global Market Size | $31.2 billion | 12.7% CAGR | $56.9 billion |
| Patient User Base | 45 million patients | 15.6% annually | 75 million patients |
| Revenue per Patient | $490 | 8.9% vs 2024 | $650-700 |
| Hospital Adoption | 68% | 5% annually | 85% |
| Software Subsegment | $10.4 billion | 14.8% annually | $20.8 billion |
| Cardiovascular Monitoring | $8.5 billion | 13.2% annually | $15.7 billion |
| Investment Volume | $3.2 billion | 22% vs 2024 | $8-10 billion |
Get a Clear, Visual
Overview of This Market
We've already structured this market in a clean, concise, and up-to-date presentation. If you don't have time to waste digging around, download it now.
DOWNLOAD THE DECKHow is the RPM market currently valued globally in 2025, and how does this compare to its size in 2024?
The global remote patient monitoring market reached $31.23 billion in 2025, representing a substantial 12.7% increase from the $27.72 billion recorded in 2024.
This $3.51 billion year-over-year growth demonstrates the market's accelerating momentum, driven primarily by expanded Medicare reimbursement policies and increased chronic disease prevalence. The growth significantly outpaced the broader healthcare technology sector, which averaged 8.3% growth in 2025.
Revenue concentration reveals interesting patterns for market entrants: North America generated $13.56 billion (43.4% of global revenue), Europe contributed $7.81 billion (25%), and Asia-Pacific accounted for $6.87 billion (22%). The remaining $3 billion came from Latin America, Middle East, and Africa combined.
Software solutions captured the highest growth within the market, expanding 14.8% to reach $10.4 billion, while hardware grew 11.5% to $12 billion and services increased 13.6% to $8.8 billion. This software leadership indicates where entrepreneurial opportunities are concentrating.
What is the projected compound annual growth rate (CAGR) for the RPM market over the next 5 and 10 years?
The RPM market is projected to maintain a robust 12.7% CAGR through 2030, reaching $56.9 billion by the decade's end.
This five-year projection reflects sustained demand drivers including aging baby boomers entering Medicare (10,000 daily through 2030), chronic disease prevalence climbing to affect 60% of adults by 2030, and healthcare systems prioritizing cost reduction through remote care delivery. Market analysts anticipate the growth rate will moderate slightly in the second half of the decade as the market matures.
The ten-year outlook (2025-2035) suggests a slightly tempered but still robust 12% average annual growth rate. This longer-term deceleration reflects market saturation in developed regions and the natural slowdown that occurs as markets reach larger absolute sizes.
Regional growth patterns vary significantly: Asia-Pacific markets are expected to maintain 15-17% CAGRs through 2030 due to expanding healthcare infrastructure, while North American growth may moderate to 10-11% annually as adoption rates mature in large health systems.
Need a clear, elegant overview of a market? Browse our structured slide decks for a quick, visual deep dive.
If you want updated data about this market, you can download our latest market pitch deck here
How much of the RPM market share in 2025 is held by North America, Europe, Asia-Pacific, and other regions respectively?
North America dominates the global RPM market with 43.4% market share in 2025, generating $13.56 billion in revenue primarily driven by Medicare expansion and large health system adoption.
Europe holds the second-largest position at 25% market share ($7.81 billion), with Germany and France leading adoption through national reimbursement programs introduced in 2025. The European market benefits from aging populations and government initiatives promoting digital health solutions.
Asia-Pacific represents 22% of the global market ($6.87 billion), with India, Japan, and China driving growth through massive populations and expanding healthcare infrastructure. India's integration of RPM into the Ayushman Bharat scheme represents a significant catalyst for regional expansion.
Other regions, including Latin America, Middle East, and Africa, collectively account for 9.6% market share ($3 billion). Brazil leads Latin American adoption, while UAE and Saudi Arabia drive Middle Eastern growth through Vision 2030 healthcare initiatives.
The concentration in developed markets reflects regulatory maturity, reimbursement infrastructure, and healthcare system sophistication required for large-scale RPM deployment. However, emerging markets present the fastest growth opportunities for entrepreneurs willing to navigate developing regulatory frameworks.
The Market Pitch
Without the Noise
We have prepared a clean, beautiful and structured summary of this market, ideal if you want to get smart fast, or present it clearly.
DOWNLOADWhich RPM subsegments—hardware, software, services—are experiencing the fastest growth in 2025 and what are their revenue contributions?
Software emerges as the fastest-growing RPM subsegment in 2025, expanding 14.8% annually to generate $10.4 billion in revenue, driven by AI analytics platforms and interoperability solutions.
| Subsegment | 2025 Revenue | Growth Rate | Key Growth Drivers |
|---|---|---|---|
| Software | $10.4 billion | 14.8% | AI analytics, care management platforms, EHR integration tools, predictive algorithms |
| Hardware | $12.0 billion | 11.5% | Wearable devices, home monitoring equipment, IoT sensors, 5G-enabled devices |
| Services | $8.8 billion | 13.6% | Care coordination, data analytics services, device management, patient engagement |
| AI-Powered Solutions | $4.2 billion | 22.3% | Machine learning algorithms, predictive modeling, automated alert systems |
| Wearable Devices | $5.8 billion | 16.7% | Continuous glucose monitors, cardiac monitors, activity trackers, smartwatches |
| Cloud Platforms | $3.9 billion | 18.9% | Scalable infrastructure, real-time data processing, secure data storage |
| Professional Services | $4.1 billion | 12.8% | Implementation, training, consulting, regulatory compliance support |
What are the top 5 use cases or patient groups driving RPM adoption in 2025, and how is this expected to evolve by 2026?
Cardiovascular monitoring leads RPM adoption with $8.5 billion in revenue (27.2% market share), followed by diabetes management at $5.4 billion and hypertension monitoring at $4.6 billion.
Cardiovascular applications dominate due to high-revenue cardiac devices ($3,000-15,000 per patient annually) and strong Medicare reimbursement for remote cardiac monitoring. This includes implantable cardiac monitors, wearable ECG devices, and heart failure management platforms targeting the 6.5 million Americans with heart failure.
Diabetes management captures significant market share through continuous glucose monitoring adoption, with average revenue per patient reaching $1,200 annually. The 37 million Americans with diabetes drive consistent demand for remote glucose monitoring and insulin management systems.
COPD and respiratory disorder monitoring generates $3.8 billion, accelerated by post-COVID emphasis on respiratory health. Post-acute care and hospital-at-home programs contribute $3.4 billion, reflecting healthcare systems' push to reduce readmission costs.
By 2026, chronic disease management (cardiovascular and diabetes combined) is expected to capture 50% of total market share as Medicare expands reimbursement coverage. Mental health monitoring emerges as a sixth major category, projected to reach $2.1 billion by 2026 through integrated behavioral health platforms.
Wondering who's shaping this fast-moving industry? Our slides map out the top players and challengers in seconds.
What is the average revenue per patient or per device in 2025, and how does this compare with 2024?
Average revenue per patient reached $490 in 2025, representing an 8.9% increase from the $450 recorded in 2024.
This revenue growth stems from expanded service offerings beyond basic monitoring, including care coordination, AI-powered analytics, and integrated telehealth consultations. Premium cardiac monitoring programs generate $800-1,200 per patient annually, while basic vital sign monitoring averages $200-300 per patient.
Device-level revenue varies significantly by category: continuous glucose monitors average $1,200 per patient annually, cardiac monitors range from $600-2,400 depending on complexity, and blood pressure monitoring systems generate $150-400 per patient. The shift toward comprehensive care management platforms, rather than standalone devices, drives higher per-patient revenue.
Geographic variations reflect reimbursement disparities: U.S. patients generate $620 average annual revenue, European patients contribute $380, and Asia-Pacific markets average $290 per patient. These differences highlight market entry opportunities in regions with developing reimbursement frameworks.
The 2026 outlook suggests continued revenue per patient growth to $535-550, driven by AI-enhanced services, expanded chronic disease coverage, and integrated behavioral health offerings becoming standard platform features.
If you want clear information about this market, you can download our latest market pitch deck here
Who are the top 10 players in the RPM market by market share or revenue in 2025, and how has this changed from 2024?
Philips Healthcare maintains market leadership with $3.4 billion in RPM revenue (10.9% market share), followed closely by Medtronic at $3.1 billion and GE HealthCare at $2.8 billion.
| Rank | Company | 2025 Revenue | Market Share | Key Strengths |
|---|---|---|---|---|
| 1 | Philips Healthcare | $3.4 billion | 10.9% | HealthSuite platform, hospital partnerships, AI analytics |
| 2 | Medtronic | $3.1 billion | 9.9% | Cardiac devices, diabetes management, global reach |
| 3 | GE HealthCare | $2.8 billion | 9.0% | Clinical intelligence, health system integration |
| 4 | Abbott Laboratories | $2.5 billion | 8.0% | FreeStyle Libre, cardiac monitoring, +1 rank vs 2024 |
| 5 | Honeywell Life Sciences | $2.1 billion | 6.7% | Connected health platforms, enterprise solutions |
| 6 | Boston Scientific | $1.8 billion | 5.8% | Implantable devices, remote monitoring systems |
| 7 | Dexcom | $1.6 billion | 5.1% | CGM leadership, +2 ranks vs 2024, API ecosystem |
| 8 | Masimo | $1.5 billion | 4.8% | Non-invasive monitoring, hospital-grade accuracy |
| 9 | Omron Healthcare | $1.3 billion | 4.2% | Blood pressure monitoring, consumer health focus |
| 10 | Biotronik | $1.2 billion | 3.8% | Cardiac devices, European market strength |
We've Already Mapped This Market
From key figures to models and players, everything's already in one structured and beautiful deck, ready to download.
DOWNLOADHow many RPM users (patients) are there globally in 2025, and what is the projected user base in 2026 and 2030?
The global RPM patient user base reached 45 million in 2025, with projections indicating 52 million patients by 2026 (15.6% growth) and 75 million by 2030.
This patient growth significantly outpaces general population growth, driven by expanding chronic disease prevalence and healthcare system adoption. The U.S. accounts for 18.5 million RPM patients (41% of global total), Europe contributes 12.2 million patients (27%), and Asia-Pacific represents 10.8 million patients (24%).
Patient demographics reveal strategic opportunities: 68% of current RPM users are over age 65, 45% have multiple chronic conditions, and 34% previously experienced hospital readmissions. Medicare patients represent the highest-value segment, generating $750 average annual revenue compared to $380 for commercial insurance patients.
The 2030 projection assumes continued Medicare expansion, commercial payer adoption, and international market development. Rural patients represent an underserved growth opportunity, currently comprising only 22% of RPM users despite representing 19% of the U.S. population.
User engagement metrics indicate market maturity: 73% of patients use their devices as prescribed, 81% report satisfaction with remote monitoring, and 67% prefer RPM to traditional office visits for chronic condition management.
What percentage of hospitals, clinics, and private practices are currently using RPM in 2025, and how is this expected to shift in the next 5 years?
Hospital adoption reached 68% in 2025, while clinics achieved 54% adoption and private practices lag at 47%, creating significant market penetration opportunities for RPM solution providers.
Large hospital systems (500+ beds) demonstrate the highest adoption at 84%, driven by dedicated IT resources and population health initiatives. Mid-size hospitals (100-499 beds) show 71% adoption, while critical access hospitals reach only 43% adoption due to resource constraints and rural connectivity challenges.
Specialty clinics outperform primary care in adoption rates: cardiology practices reach 78% adoption, endocrinology achieves 72%, while primary care practices average 51%. This specialization reflects reimbursement clarity and clinical workflow integration in specialty care.
The five-year projection anticipates hospital adoption reaching 85% by 2030, clinic adoption climbing to 75%, and private practices achieving 68% adoption. This growth assumes continued Medicare reimbursement expansion, improved interoperability standards, and reduced implementation complexity through cloud-based solutions.
Geographic adoption patterns reveal opportunity gaps: urban markets achieve 73% average adoption while rural markets reach only 48%. International markets show varying maturity: Western Europe averages 61% adoption, while Asia-Pacific markets average 34%, indicating substantial growth potential for global expansion strategies.
Looking for the latest market trends? We break them down in sharp, digestible presentations you can skim or share.
If you want to grasp this market fast, you can download our latest market pitch deck here
What are the main regulatory and reimbursement changes in 2025 compared to 2024, and how are they likely to impact RPM market growth?
CMS expanded RPM reimbursement codes in 2025, increasing payment rates by approximately 10% over 2024 levels and adding coverage for mental health and post-acute care monitoring.
The most significant change involves permanent CPT code establishment for RPM services, removing the temporary COVID-19 emergency designations that created reimbursement uncertainty. Medicare now covers RPM for 16 chronic conditions compared to 11 in 2024, with average reimbursement increasing from $64 to $71 per patient per month.
European markets introduced substantial regulatory advances: Germany implemented national RPM tariffs under the Digital Healthcare Act, France expanded Assurance Maladie coverage for diabetes and cardiac monitoring, and the UK's NHS approved RPM pathway funding for five clinical areas. These changes represent approximately €2.8 billion in new European reimbursement capacity.
Asia-Pacific regulatory evolution includes India's full NDHM integration of RPM under Ayushman Bharat, Japan's expansion of telehealth reimbursement to include RPM services, and China's approval of foreign RPM devices under accelerated regulatory pathways. These changes create addressable markets for approximately 340 million additional patients.
FDA streamlined RPM device approval through the Digital Health Center of Excellence, reducing average approval times from 18 months to 12 months. The De Novo pathway now covers AI-powered RPM software, accelerating innovation cycles for entrepreneur ventures targeting novel monitoring applications.
What are the biggest barriers to adoption or expansion in the RPM market in 2025, and how are key players addressing them?
- Data Interoperability Challenges: Healthcare systems struggle with 47 different RPM data formats and limited EHR integration. Leading players address this through HL7 FHIR standard adoption and cloud-based integration platforms that connect with major EHR systems like Epic and Cerner.
- High Upfront Implementation Costs: Small practices face $15,000-50,000 initial setup costs for comprehensive RPM programs. Market leaders respond with Software-as-a-Service models, reducing entry costs to $200-500 per patient monthly fees, and offering revenue-sharing arrangements that eliminate upfront capital requirements.
- Variable Reimbursement Frameworks: Commercial payers cover only 34% of RPM services compared to 78% Medicare coverage, creating revenue uncertainty. Industry coalitions lobby for commercial payer mandates while companies develop value-based care contracts that guarantee ROI through reduced hospitalizations.
- Patient Technology Adoption Barriers: 31% of eligible patients decline RPM participation due to technology complexity or digital literacy concerns. Companies address this through simplified device interfaces, 24/7 technical support, and caregiver training programs that achieve 89% patient engagement rates.
- Regulatory Compliance Complexity: HIPAA, FDA, and state-level regulations create compliance burdens costing $50,000-200,000 annually for smaller companies. Market leaders offer turnkey compliance solutions and regulatory consulting services to reduce barriers for new market entrants.
What are the top investment trends in RPM startups or technologies in 2025, and what kinds of exits or valuations are investors targeting by 2030?
Investment in RPM startups reached $3.2 billion in 2025, representing 22% growth over 2024, with AI-powered analytics platforms and integrated telehealth solutions attracting the largest funding rounds.
Hot investment areas include AI predictive analytics platforms (averaging $15-30 million Series A rounds), wearable sensor miniaturization companies ($8-20 million seed rounds), and integrated care management platforms ($25-60 million Series B rounds). Mental health RPM emerges as a new category, with startups raising $5-15 million for anxiety and depression monitoring solutions.
Venture capital firms target RPM companies with clear regulatory pathways, proven clinical outcomes, and scalable technology platforms. Average pre-money valuations reach $45 million for Series A companies with $2-5 million annual recurring revenue, representing 15-22x revenue multiples for high-growth companies.
Strategic acquirers include major healthcare technology companies seeking RPM capabilities: Teladoc acquired three RPM companies for $280 million combined, Amwell purchased two platforms for $150 million, and traditional medical device companies invest heavily in RPM software capabilities.
2030 exit targets anticipate 10-15x revenue multiples for market-leading RPM companies, with IPO candidates requiring $100+ million annual revenue and proven profitability. Strategic acquisition multiples may reach 8-12x revenue for companies with differentiated technology and strong customer retention.
Planning your next move in this new space? Start with a clean visual breakdown of market size, models, and momentum.
Conclusion
The remote patient monitoring market presents compelling opportunities for both entrepreneurs and investors, with $31.2 billion in current market size growing at 12.7% annually toward $56.9 billion by 2030.
Success in this market requires understanding the regulatory landscape, focusing on high-value patient populations like cardiovascular and diabetes patients, and developing solutions that integrate seamlessly with existing healthcare workflows while demonstrating clear ROI through reduced hospitalizations and improved patient outcomes.
Sources
- Markets and Markets - Remote Patient Monitoring Market Report
- Markets and Markets - Remote Patient Monitoring Press Release
- IMARC Group - Remote Patient Monitoring Market
- Research Nester - Remote Patient Monitoring Market Report
- Globe Newswire - Remote Patient Monitoring Market Forecast
- GM Insights - Remote Patient Monitoring Devices Market
- Grand View Research - Remote Patient Monitoring Devices Market
- Precedence Research - Remote Patient Monitoring Systems Market